Press release
US Generic Drug Market Opportunity Outlook 2020 Report
* Introduction to US Generic Drugs Market
* Hatch-Waxman Act & Its Implication
* FDA Review on Generic Drugs
* Supportive Features of US Generic Drug Laws
* Effect of Generic Drug Import on US Economy
* Methods to Achieve Higher Cost Arbitrage by Generic Drugs
* Role of Online Pharmacies in Expansion of US Generic Drugs Market
* US Generic Drugs Market Future Prospects
Download Report Sample Weblink:
https://www.kuickresearch.com/report-US-Generic-Drug--Market-Opportunity-Outlook-2020.php
For Report Sample Contact: neeraj@kuickresearch.com
Table of Contents
1. Introduction to US Generic Drugs Market
2. Hatch-Waxman Act & Its Implication
2.1 Premises of Hatch-Waxman Act
2.2 Benefits of Hatch-Waxman Act
2.3 Differential Measures in Hatch-Waxman Act
3. FDA Review on Generic Drugs
4. US Generic Drugs Market Overview
5. Supportive Features of US Generic Drug Laws
5.1 Features Considered by Generic Drug Developers
5.2 Factors Leading to Market Introduction of Generic Drugs
6. Patient Protection & Affordable Care Act (PPACA)
6.1 Objectives of Patient Protection & Affordable Care Act (PPACA)
6.2 Affordable Care Act & Savings on Generic Drug
6.3 Pharmacy Benefit Manager (PBM)
6.3.1 Pharmacy Networks
6.3.2 Mail Service Pharmacies
6.3.3 Health Information Technology (HIT)
6.4 Impact on Medicare Beneficiaries
7. Advancements in US Generic Drugs Market
7.1 Electronic Submission for Improved Processivity
7.2 Generic Drug User Fee Amendments (GDUFA) Fees
7.3 Fair Access for Safe & Timely Generics Act
8. Business Strategies of Branded & Generic Drug Manufacturers in US
8.1 Outsourcing of Research & Development
8.2 Merger & Acquisition by Branded Drug Companies
8.3 Marketing of Branded Drug in Generic Market
8.4 Monopoly in Generic Drug Manufacturing
8.5 Outsourcing Manufacturing to Emerging Countries
9. Methods to Achieve Higher Cost Arbitrage by Generic Drugs
9.1 Health Insurance Plans
9.2 Automatic Generic Substitution
9.2.1 Measures Taken for Generic Substitution
9.2.2 Counter Arguments against Generic Substitution
9.3 Cost Saving Plans by Retail Chains
9.4 Innovative Methods to Save Money on Generic Drug Prescription
10. Market Scenario of Branded & Generic Drugs in US
11. Effect of Generic Drug Import on US Economy
11.1 Why US Needs Generic Drug Import?
11.2 Factors Favoring Increase of Generic Drug Manufacturers in Emerging Countries
11.2.1 Regulatory Framework
11.2.2 Patent Loss
11.2.3 Increasing Number of Generic Drug Manufacturers
11.2.4 Implementation of International Standards
11.2.5 Lower Production Costs
11.3 US as Largest Importer of Generic Drugs
11.4 Potential Threat to US Generic Imports
12. Role of Online Pharmacies in Expansion of US Generic Drugs Market
13. US Generic Drugs Market Dynamics
13.1 Increasing Health Expenditure
13.2 Increasing Disease Incidences
13.3 Ageing US Population
13.4 Implementation of Hatch-Waxman Act
13.5 Patent Expiry of Blockbuster Drugs
13.6 Easy Manufacturing of Generic Drugs
13.7 Outsourcing Generic Drugs
13.8 Amenable Regulations
13.9 Implementation of Affordable Care Act
14. US Generic Drugs Market Commercialization Challenges
14.1 Patent Infringement Lawsuits
14.2 Lack of New Generic Drugs
14.3 Increasing Prices of Generic Drugs
14.4 Difficult Regulation of Generic Drugs
15. US Disease Profiling
15.1 Increasing Cancer Incidences
15.2 Cardiovascular Ailments
15.3 Central Nervous System (CNS) Diseases
15.3.1 Epilepsy
15.3.2 Alzheimer’s Disease
15.3.3 Parkinson’s Disease
16. US Generic Drugs Market Future Prospects
17. Competitive Landscape
17.1 Accord Healthcare
17.2 Alvogen
17.3 Amneal Pharmaceuticals
17.4 ANI Pharmaceuticals
17.5 Apotex
17.6 Aurobindo Pharma
17.7 Baxter Healthcare Corporation
17.8 Dr. Reddy's Laboratories
17.9 Fresenius Kabi
17.10 G & W Laboratories
17.11 Glenmark Generics
17.12 lmpax Laboratories
17.13 Lupin Pharmaceuticals
17.14 Mallinckrodt Pharmaceuticals
17.15 Momenta Pharmaceuticals
17.16 Mylan
17.17 Par Pharmaceutical
17.18 Perrigo Company
17.19 Sagent Pharmaceuticals
17.20 Sandoz
17.21 Sun Pharmaceutical Industries
17.22 Teva Pharmaceuticals
17.23 Therapeutic Proteins International
17.24 West- Ward Pharmaceuticals
17.25 Wockhardt
17.26 Zydus Pharmaceuticals
Figure 1-1: Difference between Generic & Branded Drugs
Figure 1-2: Similarities between Generic vs. Branded Drugs
Figure 1-3: Factors Responsible for Lesser Prices of Generic Drugs
Figure 1-4: Misconceptions Related to Generic Drugs
Figure 2-1: Main Premises of Hatch-Waxman Act
Figure 2-2: Implications of Hatch-Waxman Act
Figure 3-1: Application Required for Different Drugs
Figure 3-2: Benefits of New Chemical Entity
Figure 3-3: Increasing Generic Trade in US
Figure 3-4: Issues with Labelling of Generic Drugs
Figure 3-5: Patent Evergreening to Prevent Generic Drugs
Figure 4-1: Market Shares Occupied by Generic Drugs in US
Figure 4-2: Generic Drug Savings in US (Billion US$), 2005-2014
Figure 4-3: Generic Drug Saving in US by Therapy (Billion US$)
Figure 4-4: Generic Drugs Saving by Payer (%)
Figure 5-1: Features Considered by Generic Drug Developers
Figure 5-2: Factors Leading to Market Introduction of Generic Drugs
Figure 5-3: Approval Process of Generic Drugs
Figure 5-4: New Drug Application (NDA) for Branded Drugs
Figure 6-1: Objectives of Affordable Care Act
Figure 6-2: Offering Made by Affordable Care Act
Figure 6-3Objectives of Pharmacy Benefit Manager (PBM)
Figure 6-4: Different Roles Played by Pharmacy Benefit Manager (PBM)
Figure 7-1: Improvements in US Generic Market
Figure 8-1: Various Strategies Employed by Branded & Generic Drug Manufacturers
Figure 9-1: Few Methods to Achieve Higher Cost Arbitrage
Figure 9-2: Types of Managed Care Plan
Figure 9-3: Walmart’s Generic Drug Business Model
Figure 9-4: Benefits of Pill Splitting
Figure 10-1: Types of Drugs Available in US Pharmaceuticals Market
Figure 11-1: Favorable factors for Generic Drug Manufacturing in Emerging Countries
Figure 12-1: Mode of Operation of Online Pharmacies
Figure 12-2: Benefits of Online Pharmacy
Figure 13-1: Favorable Market Factors
Figure 13-2: Estimated Number of Older People (65 years of more) in US, 2020, 2040 & 2060
Figure 14-1: Commercialization Challenges
List of Tables
Table 2-1: Benefits of Hatch-Waxman Act
Table 4-1: Generics Drug Saving by State (US$)
Table 7-1: Generic Drug User Fee Amendments (GDUFA) Fees, Financial Year 2016
Table 9-1: Different Co-Pays According to Health Insurance Plan
Table 9-2: Few Important Drug Substitution Laws in US
Table 10-1: Prospective of US Patients on Generics & Branded Drugs
Table 10-2: Few Most Prescribed Branded Drugs in US, 2015
Table 10-3: Few Important Generic Drugs in US
Table 15-1: Few Generic & Branded Drugs for Cardiovascular Ailments
Table 15-2: Few Generic & Branded Drugs for Epilepsy available in US
Table 15-3: Few Alzheimer’s Disease Generic & Branded Drugs available in US
Table 15-4: Few Generic & Branded Drugs for Parkinson’s available in US
Kuick Research is a market research and analytics company that provides targeted information for critical decisions at business, product and service levels. We are quick, predictive and known by the recommendations we have made in the past. Our result-oriented research methodology offers understanding of multiple issues in a short period of time and gives us the capability to keep you full with loads of practical ideas. By translating research answers into strategic insight and direction, we not only rate the success potential of your products and/or services, but also help you identify the opportunities for growth in new demographies and find ways to beat competition.
Neeraj Chawla
neeraj@kuickresearch.com
KuicK Research
L29 - L34, First Floor
Block L,Connaught Place
New Delhi-110001
+91-11-47067990
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release US Generic Drug Market Opportunity Outlook 2020 Report here
News-ID: 1040965 • Views: …
More Releases from Kuick Resarch
Targeted Alpha Therapy Market
Global Targeted Alpha Therapy Market Size, Drugs Approval, Proprietary Technologies & Clinical Trials Insight 2028 Report Highlights:
• Global Targeted Alpha Therapy Market Insight By Region
• Approved Targeted Alpha Therapy Dosage & Pricing Insight
• Number Of Targeted Alpha Therapy In Clinical Trials: > 20 Drugs
• Targeted Alpha Therapy Clinical Trials Insight By Company, Country, Indication & Phase
• Marketed Targeted Alpha Therapy Clinical Insight By Company, Country & Indication
• Targeted Alpha Therapy Proprietary Technology Platform Insights By…
Global Cancer Antibody Drug Conjugates Market
Global Cancer Antibody Drug Conjugates Market Size, Drugs Approval, Price, Sales & Clinical Trials Insight 2030 Report Finding & Inclusions:
• Global Cancer Antibody Drug Conjugates Market: 2020 - 2030
• Global Cancer Antibody Drug Conjugates Market Opportunity > US$ 50 Billion By 2030
• Approved Cancer Antibody Drug Conjugates: 16 Drugs
• Approved Cancer Antibody Drug Conjugates Sales Insights, Patent, Dosage and Price Analysis
• Cancer Antibody Drug Conjugates In Clinical Trials: > 500 Drugs
• Cancer Antibody Drug Conjugates Clinical…
Cancer Peptide Drugs Market
Global Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030 Report Highlights:
• Global Peptide Cancer Drug Market Insight By Region & Indication
• Global Peptide Cancer Drug Market Opportunity: > US$ 18 Billion
• Approved Peptide Cancer Drugs: > 30 Drugs
• Approved Peptide Cancer Drugs Sales Insights, Patent, Dosage and Price Analysis
• Peptide Cancer Drugs Clinical Trials Insight By Company, Country, Indication and Phase
• Insight On Peptide Cancer Drugs In Clinical Trials: >…
Bispecific Antibody Drug Conjugates Development
The development of bispecific antibody drug conjugates (ADCs) marks a significant advancement in the field of targeted cancer therapy. These innovative molecules combine the specificity of bispecific antibodies with the powerful cytotoxic effects of drug conjugates, creating a new class of therapeutic agents that hold great promise for treating complex and resistant cancers. The process of developing these ADCs involves intricate design, engineering, and testing to ensure their safety, efficacy,…
More Releases for Generic
Prominent Generic Oncology Drugs Market Trend for 2025: Novel Formulations Trans …
Which drivers are expected to have the greatest impact on the over the generic oncology drugs market's growth?
The upward trend in cancer incidence is predicted to fuel the expansion of the generic oncology drugs market. Cancer, characterized by unregulated cell proliferation affecting numerous organs, results in considerable morbidity and mortality globally. The provision of affordable generic oncology drugs is an instrumental factor in cancer care, expanding access to vital treatments,…
Generic Theater Presents Flyin' West
NORFOLK, VA (August 2023) - Generic Theater inaugurates its 43rd season with Flyin' West, written by award-winning playwright and New York Times bestselling author Pearl Cleage. Terrance Afer-Anderson directs this production, running weekends September 8th - October 1st at Generic Theater, Norfolk's underground theater located in the basement of Chrysler Hall.
Following the end of the Civil War, many former slaves took advantage of The Homestead Act and went West to…
Generic Injectables Market growth is attributed to the increasing demand for Onc …
According to Precision Business Insights (PBI), the latest report, the generic injectables market will be worth USD 22.0 billion in 2022, growing at an 11.0% CAGR from 2022 to 2028. The global generic injectables market is segmented into the following types: Product Type (Monoclonal Antibodies, Cytokines, Insulin, Peptide Hormones, Blood Factors, Immunoglobulins, Peptide Antibiotics, Vaccines, and Others), Indication (Diabetes, Cancer, Cardiovascular Diseases, Musculoskeletal, CNS, Infections, and Others), Distribution Channel (Hospital…
A Demand On Generic Drugs Market And The Need To Push The Market Of Generic Drug …
Global Generic Drugs Market
A generic drug is pharmaceutical drug, which is bio-equivalent to a branded drug in all forms such as route of administration, strength, dosage, quality, intended use and performance. Generic drugs are usually approved after patent expiration of patent drugs. Generic drugs are safe, effective and FDA approved. The global market is filled with 44% of generic drugs.
The global generic drugs market is driven by the rise of…
Generic Drug Market: Global Generic Drug Share to Reach USD 380.60 Billion by 20 …
Zion Market Research has published a new report titled “Generic Drug Market by Brand (Pure Generic and Branded Generic) for Central Nervous System (CNS), Cardiovascular, Dermatology, Oncology, Respiratory and Others Therapeutic Applications - Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 – 2021”. According to the report, the global generic drug market accounted for around USD 200.20 billion in 2015 and is expected to reach approximately USD 380.60 billion by…
Generic Drugs: Global Collaboration Opportunities
Collaboration is the key to growth
With the recent economic turmoil affecting many markets around the world, the generic and branded sectors face similar problems.
At one time the generic sector was seen as a valuable way to bring effective products to a wider audience. This, allied to the rising cost of new advanced branded products, led to rapid expansion of the generics sector. Even markets traditionally based in the provision of…
